Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 1:26:100453.
doi: 10.1016/j.phro.2023.100453. eCollection 2023 Apr.

Deep learning for automated contouring of neurovascular structures on magnetic resonance imaging for prostate cancer patients

Affiliations

Deep learning for automated contouring of neurovascular structures on magnetic resonance imaging for prostate cancer patients

Ingeborg van den Berg et al. Phys Imaging Radiat Oncol. .

Abstract

Background and purpose: Manual contouring of neurovascular structures on prostate magnetic resonance imaging (MRI) is labor-intensive and prone to considerable interrater disagreement. Our aim is to contour neurovascular structures automatically on prostate MRI by deep learning (DL) to improve workflow and interrater agreement.

Materials and methods: Segmentation of neurovascular structures was performed on pre-treatment 3.0 T MRI data of 131 prostate cancer patients (training [n = 105] and testing [n = 26]). The neurovascular structures include the penile bulb (PB), corpora cavernosa (CCs), internal pudendal arteries (IPAs), and neurovascular bundles (NVBs). Two DL networks, nnU-Net and DeepMedic, were trained for auto-contouring on prostate MRI and evaluated using volumetric Dice similarity coefficient (DSC), mean surface distances (MSD), Hausdorff distances, and surface DSC. Three radiation oncologists evaluated the DL-generated contours and performed corrections when necessary. Interrater agreement was assessed and the time required for manual correction was recorded.

Results: nnU-Net achieved a median DSC of 0.92 (IQR: 0.90-0.93) for the PB, 0.90 (IQR: 0.86-0.92) for the CCs, 0.79 (IQR: 0.77-0.83) for the IPAs, and 0.77 (IQR: 0.72-0.81) for the NVBs, which outperformed DeepMedic for each structure (p < 0.03). nnU-Net showed a median MSD of 0.24 mm for the IPAs and 0.71 mm for the NVBs. The median interrater DSC ranged from 0.93 to 1.00, with the majority of cases (68.9%) requiring manual correction times under two minutes.

Conclusions: DL enables reliable auto-contouring of neurovascular structures on pre-treatment MRI data, easing the clinical workflow in neurovascular-sparing MR-guided radiotherapy.

Keywords: Artificial intelligence (AI); Contouring; Deep learning (DL); Magnetic resonance-guided radiotherapy (MRgRT); Neurovascular-sparing; Prostate cancer (PCa).

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Representative case with the penile bulb (cyan), corpus cavernosum (green), internal pudendal artery (red), and neurovascular bundle (yellow) contours on T2-weighted MRI. Axial MR images obtained at the level of the penile bulb and corpora cavernosa (A), prostate apex level (B), prostate midgland level (C), and prostate base level (D). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 2
Fig. 2
A representative example of the nnU-Net contour results after manual evaluation and correction for the internal pudendal arteries (red) and the neurovascular bundles (yellow) by three raters in the axial (A) and coronal (B) direction. Perfect interrater agreement was observed for the internal pudendal arteries between all raters and for the neurovascular bundles with rater 1 and 3. Rater 2 showed a Dice similarity coefficient of 0.90 for the left neurovascular bundle and 0.93 for the right neurovascular bundle with rater 1 and 3. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 3
Fig. 3
A representative example of the nnU-Net contour results after manual evaluation and correction for the penile bulb (cyan) and the corpora cavernosa (green) by three raters in the axial (A) and coronal (B) direction. Perfect interrater agreement was observed for the corpora cavernosa between all raters and for the penile bulb between rater 1 and 3. Rater 2 showed a Dice similarity coefficient of 0.93 for the penile bulb with rater 1 and 3. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 4
Fig. 4
Pie chart with manual correction times for each DL-generated model of three radiation oncologists (3 × 15 patients = 45).

References

    1. Henke L.E., Contreras J.A., Green O.L., Cai B., Kim H., Roach M.C., et al. Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): a 4.5-year clinical experience. Clin Oncol (R Coll Radiol) 2018;30:720–727. doi: 10.1016/J.CLON.2018.08.010. - DOI - PMC - PubMed
    1. Chin S., Eccles C.L., McWilliam A., Chuter R., Walker E., Whitehurst P., et al. Magnetic resonance-guided radiation therapy: a review. J Med Imaging Radiat Oncol. 2020;64:163–177. doi: 10.1111/1754-9485.12968. - DOI - PubMed
    1. Murray J., Tree A.C. Prostate cancer – Advantages and disadvantages of MR-guided RT. Clin Transl Radiat Oncol. 2019;18:68. doi: 10.1016/J.CTRO.2019.03.006. - DOI - PMC - PubMed
    1. Loi M., Wortel R.C., Francolini G., Incrocci L. Sexual function in patients treated with stereotactic radiotherapy for prostate cancer: a systematic review of the current evidence. J Sex Med. 2019;16:1409–1420. doi: 10.1016/J.JSXM.2019.05.019. - DOI - PubMed
    1. ClinicalTrials.gov. National Library of Medicine (U.S.) (2018, April 24). Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C). Identifier NCT03525262. Accessed October 1, 2022. https://clinicaltrials.gov/ct2/show/NCT03525262.

LinkOut - more resources